660 related articles for article (PubMed ID: 1386885)
1. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
[TBL] [Abstract][Full Text] [Related]
2. Differential effect of pH on thromboxane A2/prostaglandin H2 receptor agonist and antagonist binding in human platelets.
Mayeux PR; Morinelli TA; Williams TC; Hazard ES; Mais DE; Oatis JE; Baron DA; Halushka PV
J Biol Chem; 1991 Jul; 266(21):13752-8. PubMed ID: 1830308
[TBL] [Abstract][Full Text] [Related]
3. Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptors.
Okwu AK; Ullian ME; Halushka PV
J Pharmacol Exp Ther; 1992 Jul; 262(1):238-45. PubMed ID: 1378092
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of ligand binding to thromboxane A2/prostaglandin H2 receptors by diethylpyrocarbonate. Protection by receptor ligands and reversal by hydroxylamine.
Schrör K; Davis-Bruno K; Halushka PV
Biochem Pharmacol; 1995 Mar; 49(7):921-7. PubMed ID: 7741764
[TBL] [Abstract][Full Text] [Related]
5. Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist.
Morinelli TA; Oatis JE; Okwu AK; Mais DE; Mayeux PR; Masuda A; Knapp DR; Halushka PV
J Pharmacol Exp Ther; 1989 Nov; 251(2):557-62. PubMed ID: 2530338
[TBL] [Abstract][Full Text] [Related]
6. Platelet and vascular thromboxane A2/prostaglandin H2 receptors. Evidence for different subclasses in the rat.
Masuda A; Mais DE; Oatis JE; Halushka PV
Biochem Pharmacol; 1991 Jul; 42(3):537-44. PubMed ID: 1830482
[TBL] [Abstract][Full Text] [Related]
7. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe.
Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC
Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474
[TBL] [Abstract][Full Text] [Related]
8. Distinct platelet thromboxane A2/prostaglandin H2 receptor subtypes. A radioligand binding study of human platelets.
Dorn GW
J Clin Invest; 1989 Dec; 84(6):1883-91. PubMed ID: 2531760
[TBL] [Abstract][Full Text] [Related]
9. Mechanism for homologous downregulation of thromboxane A2 receptors in cultured human chronic myelogenous leukemia (K562) cells.
Dorn GW
J Pharmacol Exp Ther; 1991 Oct; 259(1):228-34. PubMed ID: 1833525
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a thromboxane A2/prostaglandin H2 receptor in guinea pig lung membranes using a radioiodinated thromboxane mimetic.
Saussy DL; Mais DE; Dubé GP; Magee DE; Brune KA; Kurtz WL; Williams CM
Mol Pharmacol; 1991 Jan; 39(1):72-8. PubMed ID: 1824791
[TBL] [Abstract][Full Text] [Related]
11. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
Yin K; Halushka PV; Yan YT; Wong PY
J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
[TBL] [Abstract][Full Text] [Related]
12. The response to thromboxane A2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systems.
Takahara K; Murray R; FitzGerald GA; Fitzgerald DJ
J Biol Chem; 1990 Apr; 265(12):6836-44. PubMed ID: 2139029
[TBL] [Abstract][Full Text] [Related]
13. Characterization of rat glomerular thromboxane A2 receptors: comparison to rat platelets.
Folger WH; Halushka PV; Wilcox CS; Guzman NJ
Eur J Pharmacol; 1992 Sep; 227(1):71-8. PubMed ID: 1426024
[TBL] [Abstract][Full Text] [Related]
14. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
Mais DE; Burch RM; Saussy DL; Kochel PJ; Halushka PV
J Pharmacol Exp Ther; 1985 Dec; 235(3):729-34. PubMed ID: 3001275
[TBL] [Abstract][Full Text] [Related]
15. Desensitization of platelet thromboxane A2/prostaglandin H2 receptors by the mimetic U46619.
Liel N; Mais DE; Halushka PV
J Pharmacol Exp Ther; 1988 Dec; 247(3):1133-8. PubMed ID: 2974487
[TBL] [Abstract][Full Text] [Related]
16. Decrease in agonist affinity for human platelet thromboxane A2/prostaglandin H2 receptors induced by a platelet-derived supernatant.
Dorn GW; Burch RM; Kochel PJ; Mais DE; Halushka PV
Biochem Pharmacol; 1987 Jun; 36(12):1913-7. PubMed ID: 2954555
[TBL] [Abstract][Full Text] [Related]
17. Photoaffinity receptor antagonist for human platelet thromboxane A2/prostaglandin H2 receptors.
Mais DE; Liel N; Halushka PV
Biochem Pharmacol; 1990 Oct; 40(7):1457-61. PubMed ID: 2145838
[TBL] [Abstract][Full Text] [Related]
18. Binding of a novel radioiodinated thromboxane A2/prostaglandin H2 antagonist to guinea pig lung membranes.
Saussy DL; Clark PD; Gunn DL; Mais DE; Froelich LL
Eicosanoids; 1992; 5(1):1-4. PubMed ID: 1419073
[TBL] [Abstract][Full Text] [Related]
19. Binding and function of a potent new thromboxane receptor antagonist, BMS 180,291, in human platelets.
Webb ML; Liu EC; Monshizadegan H; Hedberg A; Misra RN; Goldenberg H; Harris DN
J Pharmacol Exp Ther; 1993 Mar; 264(3):1387-94. PubMed ID: 8450473
[TBL] [Abstract][Full Text] [Related]
20. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
Ohkubo S; Nakahata N; Ohizumi Y
Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
